|
|
Expression and Clinical Significance of Adipsin and A-FABP in Serum of Pregnant Diabetes Patients with Insulin Resistance |
LIAN Rong-li, ZHANG Ren-ping |
Department of Obstetrics and Gynecology,Ankang Maternal and Child Health Hospital,Ankang Shaanxi 725000 |
|
|
Abstract 【Objective】To investigate the expression and clinical significance of lipase (adipsin) and adipocyte fatty acid binding protein (A-FABP) in the serum of patients with insulin resistance in gestational diabetes (GDM).【Method】A total of 100 GDM patients admitted to Ankang Maternal and Child Health Hospital from June 2019 to June 2022 were selected as the observation group, while 100 healthy pregnant women with normal prenatal examination in the same period were selected as the control group. The levels of triglyceride (TG), total cholesterol (TC), High-density lipoprotein cholesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), fasting blood glucose (FPG), fasting insulin (FINS), glycosylated hemoglobin (HbA1c), homeostasis model insulin resistance index (HOMA-IR), adipsin, and A-FABP were compared between the two groups of pregnant women. The Spearman correlation coefficient model was used to analyze the relationship among the indexes of glycolipid metabolism, adipsin, A-FABP and HOMA-IR. The correlation between A-FABP and HOMA-IR was analyzed using unconditional logistic stepwise regression to determine the influencing factors of insulin resistance in GDM patients.【Result】The TG,FPG, HbAlc, FINS, HOMA-IR,adiposin and A-FABP of the observation group were significantly higher than those of the control group (P<0.05). However, there were no statistically significant differences in TC, HDL-C, and LDL-C between the two groups (P>0.05). The correlation analysis showed that a positive correlation with HOMA-IR with levels of FPG, HbAlc, FINS, TG, adiposin, and A-FABP showed(P<0.05). The results of multivariate logistic regression analysis showed that FPG, HbAlc, FINS, TG, adiposin, and A-FABP were the influencing factors for insulin resistance in GDM patients (P<0.05).【Conclusion 】Adipsin and A-FABP are significantly correlated with GDM insulin resistance and they are important indicators for predicting GDM insulin resistance.
|
Received: 17 August 2022
|
|
|
|
|
[1] 呼改琴,黄绡珕.妊娠期糖尿病患者分娩前血糖控制水平与剖宫产术后新生儿血糖水平的相关性分析[J].医学临床研究,2023,40(2):165-167.
[2] LMEA B, SDLRA B, DUDE A A . The association of immediate postpartum glucose values with persistent insulin resistance in patients with gestational diabetes[J].Am J Obstet Gynecol MFM,2021, 4(2):100526.
[3] 刘彩欣, 刘鹏, 周加军,等. 维持性血液透析患者Adipsin水平及其与心肌损伤标志物的相关性分析[J].检验医学与临床, 2019, 16(6):765-767.
[4] 张磊, 周艳, 闫姗姗,等. Adipsin腺病毒载体构建及对2型糖尿病大鼠的治疗作用[J].生物学杂志, 2016, 33(5):58-62.
[5] 王露, 白桦, 韩梅,等. 2型糖尿病患者血清脂肪细胞型脂肪酸结合蛋白,白细胞介素-17水平及其与下肢动脉粥样硬化病变的关系[J].中国医药导报, 2019, 16(8):116-119.
[6] 中华医学会妇产科学分会产科学组, 中华医学会围产医学分会妊娠合并糖尿病协作组. 妊娠合并糖尿病诊治指南(2014)[J].中华围产医学杂志, 2014, 17(8):537-545.
[7] 陈效琴, 赵诤. 妊娠期糖尿病患者血清和肽素水平与胰岛素抵抗和胰岛β细胞功能的相关性研究[J].检验医学与临床, 2017, 14(1):51-53.
[8] 周晴, 吴锐, 葛倩,等. 不同糖耐量人群血清adipsin水平及其与胰岛β细胞功能及胰岛素抵抗的相关性研究[J].中华糖尿病杂志, 2018, 10(6):415-419.
[9] 刘丽丽. 妊娠糖尿病患者胰岛素抵抗及胰岛β细胞功能状态变化[J].中国实用医刊, 2017, 44(2):30-33.
[10] 楼公先, 楼时先, 程秒鸳,等. 孕早期FBG、HbA1c、TC、TG联合检测在妊娠期糖尿病诊断中的应用价值分析[J].中华全科医学, 2019, 17(5):809-812.
[11] QIU Y, WANG S F, YU C, et al. Association of circulating adipsin, visfatin, and adiponectin with nonalcoholic fatty liver disease in adults:a case-control study[J].Ann Nutr Metab,2019,74(1):44-52.
[12] 陈泽衍, 陈晓静, 兰希, 等. 2型糖尿病肾病患者脂肪细胞型脂肪酸结合蛋白水平及其临床意义[J].海南医学, 2020, 31(4):429-433.
[13] 李敏, 古丽娜孜·吐尔逊, 段伯焕. 2型糖尿病合并非酒精性脂肪性肝病患者A-FABP水平与胰岛素抵抗的相关性研究[J].临床和实验医学杂志, 2017, 16(15):1487-1490.
[14] 张旭艳, 丁胜, 杨帆,等. T2DM患者血清sP-selectin、sE-selectin、A-FABP、FFA与胰岛素抵抗的关系[J].解放军预防医学杂志, 2019, 37(4):11-12.
[15] 金昕晔, 邹大进. 脂肪细胞型脂肪酸结合蛋白疫苗对高脂喂养雌鼠体重和糖耐量的影响[J].生物技术通讯, 2012,23(4):519-522. |
|
|
|